Racial and Ethnic Disparities in Diagnosis of Chronic Medical Conditions in the USA by Kim, E. J. et al.
Journal Articles Donald and Barbara Zucker School of MedicineAcademic Works
2018
Racial and Ethnic Disparities in Diagnosis of
Chronic Medical Conditions in the USA
E. J. Kim
Zucker School of Medicine at Hofstra/Northwell
T. Kim
J. Conigliaro
Zucker School of Medicine at Hofstra/Northwell
J. M. Liebschutz
M. K. Paasche-Orlow
See next page for additional authors
Follow this and additional works at: https://academicworks.medicine.hofstra.edu/articles
Part of the Internal Medicine Commons
This Article is brought to you for free and open access by Donald and Barbara Zucker School of Medicine Academic Works. It has been accepted for
inclusion in Journal Articles by an authorized administrator of Donald and Barbara Zucker School of Medicine Academic Works. For more
information, please contact academicworks@hofstra.edu.
Recommended Citation
Kim EJ, Kim T, Conigliaro J, Liebschutz JM, Paasche-Orlow MK, Hanchate AD. Racial and Ethnic Disparities in Diagnosis of Chronic
Medical Conditions in the USA. . 2018 Jan 01; 33(7):Article 4410 [ p.]. Available from:
https://academicworks.medicine.hofstra.edu/articles/4410. Free full text article.
Authors
E. J. Kim, T. Kim, J. Conigliaro, J. M. Liebschutz, M. K. Paasche-Orlow, and A. D. Hanchate
This article is available at Donald and Barbara Zucker School of Medicine Academic Works:
https://academicworks.medicine.hofstra.edu/articles/4410
Racial and Ethnic Disparities in Diagnosis of Chronic Medical
Conditions in the USA
Eun Ji Kim, MD, MS, MS1, Taekyu Kim, MBA2, Joseph Conigliaro, MD, MPH1,
Jane M. Liebschutz, MD, MPH3, Michael K. Paasche-Orlow, MD, MA, MPH4, and
Amresh D. Hanchate, PhD4,5
1Division of General Internal Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Lake Success, NY, USA;
2Massachusetts General Hospital, Boston, MA, USA; 3Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA; 4Section of
General Internal Medicine, Boston University School of Medicine, Boston, MA, USA; 5VA Boston Healthcare System, Boston, MA, USA.
BACKGROUND: There exist racial and ethnic disparities
in the prevalence of chronic medical illnesses. However, it
is unclear if the disparities arise from patients’ self-
reported estimates on these diseases and whether there
is an association between healthcare utilization and
diagnosis.
OBJECTIVE: To estimate national racial/ethnic preva-
lence of undiagnosed hypertension, diabetes, high choles-
terol, and kidney disease and identify characteristics as-
sociated with undiagnosed diseases.
DESIGN: Retrospective analysis of multi-year survey
data.
PARTICIPANTS: Adults 18 years and older who partici-
pated in the National Health and Nutrition Examination
Survey during 2011–2014 (n = 10,403).
MAIN OUTCOMES: Undiagnosed hypertension (SBP≥
140 or DBP≥ 90 on physical examination with no history
of hypertension), undiagnosed diabetes (hgba1c≥ 6.5%
with no history of diabetes), undiagnosed high cholesterol
(LDL≥ 160 mg/dL with no history of high cholesterol),
and undiagnosed kidney disease (eGFR≤ 30 with no his-
tory of kidney disease).
RESULTS: The study sample was categorized into
Whites, Blacks, Hispanics, Asians, and Other. After
adjusting for sociodemographic characteristics, Asians
had increased odds of undiagnosed hypertension (OR=
1.41 [1.06–1.86]) and diabetes (OR= 6.16 [3.76–10.08])
compared to Whites. Blacks (OR=2.53 [1.71–3.73]) and
Hispanics (OR =1.88 [1.19–2.99]) had increased odds of
undiagnosed diabetes compared to Whites. Multivariate
logistic regression analysis indicated that not having any
health insurance was associated with increased odds of
undiagnosed diabetes and hyperlipidemia (OR = 1.56
[1.00–2.44] and OR = 2.08 [1.44–3.00], respectively). A
recent healthcare visit was associated with a lower likeli-
hood of having undiagnosed hypertension (OR = 0.58
[0.41–0.83]) and diabetes (OR=0.35 [0.18–0.69]).
CONCLUSIONS: In a nationally representative cohort,
Asians had higher rates of undiagnosed hypertension
and diabetes, and all minorities were more likely to have
undiagnosed diabetes compared to Whites. Healthcare
utilization was associated with undiagnosedmedical con-
ditions. Our study showed that reliance on self-reported
data may systemically underestimate the prevalence of
chronic illnesses among minorities and further research
is needed to understand the significance of healthcare
utilization in health outcomes.
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INTRODUCTION
Hypertension and diabetes are common diseases in the USA,
affecting 30 and 12–14% of adults, respectively.1,2 Epidemio-
logic studies, based largely on surveys of self-reported health
status, show that minorities, including Asian Americans and
Hispanics, have a lower prevalence of hypertension and dia-
betes compared to other race/ethnic groups.3,4 Recent studies,
however, have shown the contrary, with Asians and Hispanics
having a high prevalence of diabetes.2,5 Based on these stud-
ies, it is important to study if racial and ethnic disparities in
self-reported chronic diseases represent the true prevalence or
underestimate the prevalence due to the lack of a diagnosis.
National governmental panels and specialty societies have
made screening recommendations to identify patients with
common medical conditions.6–9 The purposes of these screen-
ing recommendations are to identify high risk subpopulations
and provide medical care to improve public health outcomes.
Despite these screening recommendations, minorities have
lower rates of screening and subsequently lower rates of
awareness, treatment, and control of their diseases compared
to non-Hispanic Whites.1,10,11 In addition, anchoring on pre-
vious beliefs that some minorities, including Asians, have
lower prevalence of common medical conditions may ad-
versely affect the screening of these groups and potentially
worsen disparities.
Earlier version of this work was presented at the Society for General
Internal Medicine annual meeting (Washington, DC, April 2017).
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As different undiagnosed medical problems may arise from
a common source of factors, we examined a range of chronic
medical conditions (hypertension, diabetes, high cholesterol,
and kidney disease) using data from the National Health and
Nutrition Examination Survey (NHANES). We examined the
association between the prevalence of undiagnosed disease
and the presence of a routine healthcare provider and evidence
of recent healthcare utilization. In addition, we examined the
role of race/ethnicity in these associations, with Asian Amer-
icans as a distinct group, given evidence of distinct utilization
patterns for Asian Americans.
METHODS
Data
We used data from the 2011–2014 NHANES,12 a biennial
nationally representative survey that contains self-reported
information on socio-demographic background and health
status, physical examinations, and laboratory tests. We used
the last 2 cycles of the NHANES data because the survey only
started identifying and oversampling Asians in 2011–2012.
Study Population
The data contains 19,931 participants. Our study cohort
consisted of all survey respondents 18 years or older who (1)
responded to survey questionnaires on health status, (2)
underwent a physical examination with blood pressure and
body mass index (BMI) measurements, and (3) had hemoglo-
bin a1c (hgba1c), low-density lipoprotein (LDL), and creati-
nine laboratory measures. We excluded 7960 participants who
were younger than 18 years old and 1568 participants with
invalid/incomplete responses to the main covariates (six had
missing sociodemographic characteristic variables, 1098 had
invalid/incomplete physical examination, 461 had missing
laboratory measures, and three had missing responses to
healthcare utilization questions).
Primary Outcome
The main outcomes were undiagnosed hypertension, diabetes,
high cholesterol, and kidney disease. We defined undiagnosed
disease as having self-reported no previous diagnosis of a
given disease, but having abnormal blood pressure measure-
ments, laboratory test, or estimated physiologic rate at the time
of the research interview and data collection. The discordance
between the self-report and the evidence obtained at the time
of the research exam defined the status of having an undiag-
nosed disease. Undiagnosed hypertension was defined as hav-
ing systolic blood pressure ≥ 140 mmHg or diastolic blood
pressure ≥ 90 mmHg on physical examination with no history
of hypertension. The physical examination data included 1 to
4 blood pressure readings done at a single visit; in cases of
multiple readings, we used the average to identify elevated BP
status. Among 10,403 participants, 9673 had three blood
pressure readings, 692 had two readings, and 38 had only
one reading. We defined participants as having a history of
hypertension if they self-reported themselves as (1) having
been diagnosed of high blood pressure by a doctor on two or
more settings (Question: Are you told on two or more different
visits that you had hypertension, also called high blood pres-
sure?) or (2) having taken anti-hypertensive medication(s)
(Question: Because of your high blood pressures/hyperten-
sion, have you ever been told to take prescribed medicine?).
For other diseases, we defined participants as reporting a
history of diabetes, high cholesterol, or kidney disease if they
were told by a doctor or health professional that they have the
diseases (Questions: Other than during pregnancy, have you
ever been told by a doctor or health professional that you have
diabetes or sugar diabetes? Have you ever been told by a
doctor or other health professional that your blood cholesterol
level was high? Have you ever been told by a doctor or other
health professional that you had weak or failing kidneys?).
Undiagnosed diabetes was defined as having hgba1c ≥ 6.5%,
while reporting no history of diabetes, undiagnosed high cho-
lesterol was defined as having LDL ≥ 160 mg/dL while
reporting no history of high cholesterol, and undiagnosed
kidney disease was defined as having an estimated glomerular
filtration rate (eGFR) less than 30while reporting no history of
kidney disease.6,9,13 Estimated GFR was calculated using the
Modification of Diet in Renal Disease (MDRD) equation.14
Race/Ethnicity
We used self-reported race/ethnicity and categorized the
race and ethnicity indicators into five groups: non-
Hispanic Whites, non-Hispanic Blacks, Hispanics, Asians,
and Others. We were not able to identify the ethnic back-
grounds of Asians due to the lack of national origin
information in the survey.
Covariates
We identified key sociodemographic, clinical, and healthcare
utilization characteristics associated with differential risk of
undiagnosed chronic conditions. For socio-demographic var-
iables, we included gender, age, educational level, income
status, and insurance.15–20 To adjust for differences in the
prevalence of medical conditions among different age groups,
we categorized age into four groups: 18–34, 35–49, 50–64,
and 65+. Educational achievement was categorized into three
groups: less than high school diploma, high school diploma or
equivalent, and education higher than high school. Low-
income status was defined as family income ≤ 100% of the
Federal Poverty Level. We also included BMI as a covariate
due to BMI-specific screening recommendations for hyperten-
sion and diabetes. BMI was categorized into four groups:
underweight (< 18.5 kg/m2), normal weight (18.5–24.9 kg/
m2), overweight (25.0–29.9 kg/m2), and obese (≥ 30.0 kg/
m2). For healthcare utilization characteristics, we examined
whether participants reported a routine place to go for
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healthcare and whether they reported any healthcare visit in
the past year.
The survey was administered in person at the participant’s
residence using a computer-assisted personal interviewing
system. Respondents were offered the choice of being
interviewed in English or Spanish using a questionnaire, and
if either version of the questionnaire was not adequate, partic-
ipants were provided with an interpreter.
Statistical Analysis
In all our statistical analyses, we incorporated the multi-
stage stratification sampling design and sampling
weights.21 BOther^ racial/ethnic group was included in all
the analysis but not presented in the results due to the small
number of participants (n = 313). To characterize the sam-
ple population by race/ethnicity, we compared the unad-
justed prevalence of socio-demographic indicators, mea-
sures of healthcare utilization, and undiagnosed chronic
diseases. We also compared the combined prevalence of
chronic conditions including the undiagnosed rate along
with the self-reported rate. The Holm-Bonferroni sequen-
tial method was applied to account for multiple compari-
sons.22 To compare the prevalence of undiagnosed chronic
conditions while accounting for differences in the covari-
ates, we estimated two multivariate logistic models with an
indicator of undiagnosed condition as the outcome. In the
first model, we adjusted for socio-demographic indicators,
and in the second model, we also adjusted for healthcare
utilization indicators (having a place for routine healthcare
and having any healthcare visit within the past year). We
performed sensitivity analysis to examine the prevalence of
undiagnosed high cholesterol using lower thresholds
(LDL ≤ 130) (Appendix A online). We also examined
whether limited English proficiency was associated with
the likelihood of undiagnosed diseases, particularly among
Asians and Hispanics. Participants were identified as hav-
ing limited English proficiency if they used the Spanish
questionnaire or an interpreter for the survey interview.
All statistical analyses were conducted using SAS 9.4 (SAS
Institute Inc., Cary, NC. USA). The Boston University IRB
reviewed and exempted the study.
RESULTS
The study sample of 10,403 was categorized into five
groups (weighted percentages): non-Hispanic Whites
(66.6%), non-Hispanic Blacks (11.1%), Hispanics
(14.5%), Asians (5.0%), and Others (2.7%). There were
significant differences in sociodemographic, clinical, and
healthcare utilization characteristics among the different
racial/ethnic groups (P value for chi-square test of sim-
ilarity of rates across race/ethnic groups all less than
0.01) (Table 1). There were significant differences in the
percentages of racial/ethnic groups with low income and
no insurance (low income Whites = 10.9%, Blacks = 30.9%,
Hispanics = 31.7%, Asians = 13.6%; no insurance Whites =
12.4%, Blacks = 24.7%, Hispanics = 42.4%, Asians = 17.7%).
There were also significant differences in the percentages of
groups with healthcare utilization (having a routine place for
healthcare Whites = 87.2%, Blacks = 87.0%, Hispanics =
71.3%, Asians = 78.9%; having a healthcare visit within the
past yearWhites = 88.1%, Blacks = 85.7%, Hispanic = 72.4%,
Asians = 79.9%).
Table 2 shows the clinical characteristics by race and eth-
nicity. Among Asians, the majority (55.8%) had normal BMI,
whereas, in other groups, the majority of the participants were
overweight and obese. There were significant differences in
the prevalence of self-reported histories of hypertension, dia-
betes, and high cholesterol among the different groups. There
were also significant racial/ethnic differences in the percent-
ages of participants with elevated blood pressure on physical
examination, hgba1c on lab, calculated estimated GFR, and
subsequently in the prevalence of undiagnosed diabetes and
kidney disease.
After adjusting for covariates (Table 3), Asians were more
likely to have undiagnosed hypertension (OR = 1.41 [1.06–
1.86]) and diabetes (OR = 6.16 [3.76–10.08]) compared to
Whites. Blacks (OR = 2.53 [1.71–3.73]) and Hispanics (OR =
1.88 [1.19–2.99]) also had increased odds of undiagnosed
diabetes compared to non-Hispanic Whites. There were no
significant differences in the likelihood of having undiagnosed
Table 1 Characteristics of Study Sample by Race/Ethnicity
(Weighted %)
Whites Blacks Hispanics Asians P
valuea
(n =
4153)
(n =
2384)
(n =
2260)
(n =
1293)
Socio-demographic characteristics
Male 49.1 44.8 50.1 46.4 0.01
Age group
18–34 25.9 35.5 40.9 32.8 < 0.01
35–49 24.5 27.0 32.8 32.7
50–64 29.0 25.8 18.1 21.6
65 or older 20.6 11.8 8.2 12.9
Education
Less than
HS
10.9 19.5 39.7 11.9 < 0.01
HS or
equivalent
20.4 25.6 21.8 13.8
Higher
than HS
68.7 54.9 38.5 74.2
Low
income
10.9 30.9 31.7 13.6 < 0.01
No
insurance
12.4 24.7 42.4 17.7 < 0.01
Healthcare utilization characteristics
Have a routine place to go for healthcare
Yes 87.2 87.0 71.3 78.9 < 0.01
Have a healthcare visit in the past year
Yes 88.1 85.7 72.4 79.9 < 0.01
Have a routine place to go and have a healthcare visit in the past year
Yes 80.1 78.9 60.7 69.3 < 0.01
BOther^ racial/ethnic group is not presented due to small number of
participants (n = 313)
aP value is based on the chi-square test of similarity of rates across
race/ethnic groups and corrected with the Holm-Bonferroni sequential
method
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high cholesterol among the groups. Blacks were almost twice
as likely (OR = 2.05 [1.35–3.10]) to have undiagnosed kidney
disease compared to Whites. Belonging to an older age group
was associated with increased odds of having either hyperten-
sion or diabetes, and the likelihood of having either disease
increased as the age group increased. Males, compared to
females, had increased odds (OR = 1.58 [1.23–2.02]) of hav-
ing undiagnosed hypertension but decreased odds of having
undiagnosed kidney disease (OR = 0.62 [0.45–0.85]). Having
no health insurance was associated with an increased likeli-
hood of having undiagnosed diabetes (OR = 1.56 [1.00–2.44])
and undiagnosed high cholesterol (OR = 2.08 [1.44–3.00]).
Asians had a higher prevalence of undiagnosed hyperten-
sion and diabetes, relative toWhites, even after adjusting for a
routine place for healthcare and recent health care (Asians:
undiagnosed hypertension (OR = 1.36 [1.02–1.81]) and dia-
betes (OR = 5.89 [3.58–9.70])) (Table 4). After adjusting for
healthcare utilization, Blacks (OR = 2.57 [1.76–3.75]) and
Hispanics (OR = 1.80 [1.11–2.93]) also had a higher preva-
lence of undiagnosed diabetes, relative to Whites. Having a
healthcare visit in the past year was associated with decreased
odds of having undiagnosed hypertension (OR = 0.58 [0.41–
0.83]) and diabetes (OR = 0.35 [0.18–0.69]). Having a routine
place for healthcare was associated with decreased odds (OR =
0.61 [0.42–0.89]) for undiagnosed high cholesterol. Sensitiv-
ity analysis using a more stringent definition of high choles-
terol (LDL ≥ 130) showed no significant racial/ethnic differ-
ences in having undiagnosed high cholesterol. We also
Table 2 Clinical Characteristics and Observed Rates of Undiagnosed Chronic Illnesses by Race/Ethnicity (Weighted %)
Whites Blacks Hispanics Asians P valuea
Body mass index (BMI)
Underweight 1.5 2.0 0.9 4.2 < 0.01
Normal 29.6 23.5 22.7 55.8
Overweight 34.2 27.4 35.0 27.9
Obese 34.7 47.1 41.5 12.1
Hypertension
History of hypertension 31.4 36.4 19.6 18.9 < 0.01
SBP ≥ 140 or DBP ≥ 90 14.3 20.2 10.5 13.1 < 0.01
Undiagnosed hypertension 5.5 6.5 4.5 6.8 0.15
Diabetes
History of diabetes 8.6 12.2 9.5 9.6 0.03
HemoglobinA1c ≥ 6.5% 6.9 11.3 9.2 10.3 < 0.01
Undiagnosed diabetes 1.4 3.4 2.5 4.2 < 0.01
High cholesterol
History of high cholesterol 36.8 27.5 25.6 28.5 < 0.01
LDL ≥ 160 mg/dL 4.4 4.0 4.4 3.6 0.86
Undiagnosed high cholesterol 1.7 2.1 2.4 1.7 0.49
Kidney disease
History of kidney disease 2.4 2.9 2.8 1.6 0.43
EGFR ≤ 30 1.8 4.4 1.8 2.4 < 0.01
Undiagnosed kidney disease 1.6 3.4 1.3 2.2 < 0.01
aP value is based on the chi-square test of similarity of rates across race/ethnic groups and corrected with the Holm-Bonferroni sequential method
Table 3 Predictors of Undiagnosed Diseases by Race/Ethnicity (Odds Rate [95% Confidence Interval])
Overall sample (N = 10,403)
Undiagnosed
hypertension
Undiagnosed
diabetes
Undiagnosed high
cholesterol
Undiagnosed kidney
disease
Race/ethnicity (reference: non-Hispanic Whites)
Blacks 1.26 [0.94–1.69] 2.53 [1.71–3.73]* 0.96 [0.58–1.57] 2.05 [1.35–3.10]*
Hispanics 1.00 [0.74–1.35] 1.88 [1.19–2.99]* 0.79 [0.45–1.40] 0.85 [0.46–1.58]
Asians 1.41 [1.06–1.86]* 6.16 [3.76–10.08]* 1.04 [0.58–1.85] 1.33 [0.67–2.61]
Age group (reference: 18–34 years old)
35–49 2.58 [1.60–4.17]* 3.89 [1.97–7.67]* 1.73 [1.16–2.59]* 0.79 [0.44–1.43]
50–64 4.27 [2.97–6.13]* 5.89 [3.11–11.17]* 0.76 [0.43–1.36] 1.26 [0.67–2.36]
65+ 5.22 [3.72–7.33]* 7.47 [3.44–16.23]* 0.78 [0.43–1.44] 2.06 [1.15–3.70]*
Gender (reference: female)
Male 1.58 [1.23–2.02]* 1.52 [0.98–2.36] 1.09 [0.75–1.59] 0.62 [0.45–0.85]*
Education (reference: more than high school)
High school of equivalent 1.37 [0.99–1.91] 0.76 [0.44–1.34] 0.71 [0.42–1.19] 0.84 [0.55–1.27]
Less than high school 0.92 [0.66–1.28] 0.73 [0.44–1.22] 0.56 [0.32–0.99]* 0.50 [0.34–0.72]*
Income (reference: ratio of family income to poverty ≥ 100%)
Low income 0.93 [0.66–1.28] 0.91 [0.56–1.50] 1.05 [0.71–1.55] 1.12 [0.73–1.71]
Insurance (reference: have insurance)
No insurance 1.23 [0.88–1.71] 1.56 [1.00–2.44]* 2.08 [1.44–3.00]* 0.90 [0.52–1.56]
Body mass index (reference: normal)
Underweight 1.34 [0.57–3.16] – 0.59 [0.11–3.25] 1.05 [0.50–2.18]
Overweight 0.65 [0.43–0.98]* 1.97 [0.93–4.14] 1.72 [0.97–3.05] 0.47 [0.29–0.76]*
Obese 0.92 [0.63–1.36] 7.33 [3.20–16.79]* 1.55 [0.84–2.86] 0.80 [0.51–1.27]
*P value < 0.05
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Table 4 Predictors of Undiagnosed Diseases by Race/Ethnicity, Adjusted for Healthcare Utilization Characteristics (Reference: Non-Hispanic
Whites)
Undiagnosed
hypertension
Undiagnosed
diabetes
Undiagnosed high
cholesterol
Undiagnosed kidney
disease
Blacks 1.28 [0.95–1.73] 2.57 [1.76–3.75]* 0.98 [0.60–1.60] 2.03 [1.33–3.09]*
Hispanics 0.96 [0.72–1.29] 1.80 [1.11–2.93]* 0.77 [0.43–1.36] 0.87 [0.47–1.61]
Asians 1.36 [1.02–1.81]* 5.89 [3.58–9.70]* 1.01 [0.57–1.81] 1.35 [0.69–2.64]
Routine place for healthcare 0.80 [0.54–1.17] 1.32 [0.76–2.31] 0.61 [0.42–0.89]* 1.15 [0.67–1.96]
Healthcare visit in the past
year
0.58 [0.41–0.83]* 0.35 [0.18–0.69]* 0.98 [0.66–1.46] 1.40 [0.74–2.65]
The logistic regression also adjusted for gender, age group (18–34, 35–49, 50–64, and 65+), education (less than high school, HS or equivalent, and
higher than HS), low income, and insurance
*P value < 0.05
Fig. 1 a National estimate of hypertension. b National estimate of diabetes. c National estimate of high cholesterol. d National estimate of kidney
disease.
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conducted a sensitivity analysis, adjusting for limited English
proficiency (Appendix B online). We found 0.3% Whites,
0.4% Blacks, 43.4% Hispanics, and 19.2% Asians to have
limited English proficiency. When limited English proficiency
was included in the analysis, Asians no longer had an in-
creased likelihood of having undiagnosed hypertension and
Hispanics no longer had an increased likelihood of having
undiagnosed diabetes compared to Whites.
Lastly, using participants’ self-reported diagnosis and our
observed rate of undiagnosed diseases, we estimated the na-
tional prevalence of chronic medical conditions (Fig. 1). There
was a significant difference in the prevalence of kidney disease
among different racial and ethnic groups after accounting for
the prevalence of undiagnosed diseases.
DISCUSSION
Using nationally representative data, we found significant
racial/ethnic differences in the prevalence of undiagnosed
hypertension, diabetes, and kidney disease. Asians had an
increased likelihood of having both undiagnosed hypertension
and diabetes, while Blacks and Hispanics had a higher likeli-
hood of having undiagnosed diabetes compared to non-
Hispanic Whites after adjusting for sociodemographic charac-
teristics and BMI. These findings persisted even after
adjusting for having a place for routine care and having a
healthcare visit in the past year.
There are several plausible explanations for minorities
having an increased likelihood of undiagnosed medical
conditions. For Asians, anchoring on this belief that Asians
have low prevalence of certain common medical condi-
tions, including hypertension and diabetes3,4, a smaller
percentage of Asians may have sought to screen for these
common diseases, and among those who had healthcare
visits, their healthcare providers may have had higher
thresholds to screen for them. Another possibility is that
the prevalence of these common diseases may differ with
acculturation, specifically with the adoption of a Western
diet.23 As immigrant populations adapt to the Western
culture, their new disease-risk may have become similar
or even higher than the overall US population.24,25 Our
analysis examining healthcare utilization characteristics
showed that Hispanics and Asians may not be utilizing
healthcare and thus place them at an increased risk of not
having appropriate screening. This pattern of low
healthcare utilization is pervasive and includes low cancer
screening among adults and healthcare visits among chil-
dren.26,27 This is especially contradictory to Asians, who
have favorable sociodemographic characteristics, including
high percentages of Asians having high educational
achievement, middle-high income, and health insurance.
Lastly, recent studies have shown that Asians have a higher
percentage of body fat for given BMI, resulting in a higher
risk of developing diabetes at lower levels of BMI.28,29
Our study identified other characteristics of undiagnosed
diseases related to insurance and healthcare utilization. De-
spite guidelines recommending diabetes screening among
obese patients,30 we found that individuals who were obese
had a sevenfold increased odds of having undiagnosed diabe-
tes. Having no insurance was associated with an increased
likelihood of having undiagnosed diabetes and high cholester-
ol. A diagnosis of hypertension can be more conveniently
done using blood pressure machines available in public set-
tings (e.g., drug stores and supermarkets), independent of
insurance. In contrast, a diagnosis of diabetes requires labora-
tory tests or a glucometer, which are less accessible. Addition-
ally, a healthcare visit in the past year was associated with
decreased odds of having undiagnosed hypertension and dia-
betes. As blood pressure and diabetes screening are commonly
done during healthcare visits, this supports our study’s finding.
Interestingly, having a routine place for healthcare was asso-
ciated with the diagnosis of high cholesterol, but having a
healthcare visit in the past year was not. One possibility is that
additional laboratory testing, such as lipid screening, is done
during routine healthcare visits, as abnormal lab findings
require follow-up visits.
Our analysis to address limited English proficiency as a
factor in the diagnosis of medical conditions showed that
limited English proficiency was associated with a diagnosis
of diabetes. Also, adjusting for limited English proficiency
resulted in the mitigation of differences in the diagnosis of
hypertension among Asians and the diagnosis of diabetes
among Hispanics compared to Whites. This showed that dif-
ferences in the diagnosis arose from limited English proficien-
cy in certain situations, and improving patient-physician com-
munication by utilizing interpreters could potentially increase
the diagnosis of these medical conditions.
We believe that the basis of screening for these common
medical conditions is multifactorial. For common diseases
such as hypertension, there is wide acceptability of existing
guidelines. For high cholesterol and kidney diseases, guide-
lines exist, but there are conflicting recommendations regard-
ing which population should be screened and significant var-
iations in the target screening group.8,31 Additionally, screen-
ing may be influenced by the prevalence and comorbidities
associated with these diseases. Hypertension, a comorbid con-
dition for various medical conditions, has resulted in an in-
creased awareness and diagnosis of common diseases. Lastly,
the national estimate of undiagnosed diseases can be influ-
enced by the use of confirmatory diagnoses. For diabetes, the
prevalence of undiagnosed diabetes differs significantly based
on whether a single laboratory measurement is used versus a
confirmatory diagnosis (either presence of overt symptoms or
second blood sample test).5
There are several limitations to this study. We used retro-
spective cross-sectional data; therefore, the findings do not
indicate a causal relationship between race/ethnicity and un-
diagnosed medical conditions. Also, not all variables of inter-
est were available. Information on the types of healthcare
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visits would help differentiate healthcare seeking behaviors
among different groups. For example, if minorities are more
likely to seek urgent or emergency care, a potential implication
of the study is to promote preventive visits. Another limitation
arises from having blood pressure measured in a single setting;
this may have led to an over-estimation of undiagnosed hy-
pertension. Also, although we adjusted for limited English
proficiency, we were not able to adjust for health literacy,
which is a more accurate measure of a patient’s understanding
of health information. In addition, we used self-reported infor-
mation, which could result in the underreporting of medical
conditions andmedical diagnosis based on comorbidities (e.g.,
Atherosclerotic Cardiovascular Disease risk or proteinuria).
However, studies found that patients diagnosed with hyper-
tension are at least fairly accurate.32–34 Lastly, we were not
able to identify subgroups of Asians due to the lack of such
information. Currently, there are a very limited number of
national data sources that identify the national origin of
Asians. A study using state-wide data found differences in
the prevalence of these common diseases among different
subgroups,35 and thus, there is a need for data collection on
ethnicity at the national level.
There is a public need for improving screening by develop-
ing disease-specific outreach programs to improve population
health outcomes. Our study found other factors associated
with the diagnosis of medical conditions, including not having
insurance, being obese, and belonging to a certain age group.
By targeting high-risk groups or improving access to
healthcare in general, more patients could be aware of their
diseases. These preventive measures can result in significant
population-level health benefits.36
In summary, we found an increased risk of undiagnosed
medical conditions among minorities; Asians had higher rates
of undiagnosed hypertension and diabetes, and minorities had
higher rates of undiagnosed diabetes compared to non-
Hispanic Whites. As our study showed that minorities have a
higher prevalence of undiagnosed medical conditions, reliance
on self-reported data and conclusions that have been derived
from such work will need to be reevaluated. Future studies
should examine the potential sources of these disparities,
including the lack of screening37 arising at least in part from
perceptions that Asians are less likely to have hypertension or
diabetes.
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